Sudhakar Devidasrao Garad

Person

Malden, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Salt forms of ceftolozane
- Patent number 10,000,510
- Issue date Jun 19, 2018
- Merck Sharp & Dohme Corp.
- Jian-Qiao Gu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of a β-lactamase inhibitor
- Patent number 9,120,795
- Issue date Sep 1, 2015
- Cubist Pharmaceuticals, Inc.
- You Seok Hwang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vitamin E formulations of sulfamide NS3 inhibitors
- Patent number 9,011,833
- Issue date Apr 21, 2015
- Novartis AG
- Sudhakar Devidasrao Garad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...
- Patent number 8,436,177
- Issue date May 7, 2013
- Novartis AG
- Frank Stowasser
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine derivatives and their use as muscarinic M3 receptor an...
- Patent number 8,084,463
- Issue date Dec 27, 2011
- Novartis AG
- Neil J Press
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine derivatives and their use as muscarinic m3 receptor an...
- Patent number 7,723,356
- Issue date May 25, 2010
- Novartis AG
- Neil John Press
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SALT FORMS OF CEFTOLOZANE
- Publication number 20170233408
- Publication date Aug 17, 2017
- MERCK SHARP & DOHME CORP.
- Jian-Qiao Gu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR
- Publication number 20150111864
- Publication date Apr 23, 2015
- Cubist Pharmaceuticals, Inc.
- Sudhakar Garad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR
- Publication number 20140275001
- Publication date Sep 18, 2014
- You Seok Hwang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...
- Publication number 20130289064
- Publication date Oct 31, 2013
- Novartis AG
- Frank Stowasser
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VITAMIN E FORMULATIONS OF SULFAMIDE NS3 INHIBITORS
- Publication number 20130190229
- Publication date Jul 25, 2013
- Sudhakar Devidasrao Garad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR AN...
- Publication number 20100168132
- Publication date Jul 1, 2010
- Neil John Press
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...
- Publication number 20100168153
- Publication date Jul 1, 2010
- Novartis AG
- Frank Stowasser
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Organic Compounds
- Publication number 20090048281
- Publication date Feb 19, 2009
- Neil John Press
- C07 - ORGANIC CHEMISTRY

Sudhakar Devidasrao Garad

Person

Patents Grantslast 30 patents

Salt forms of ceftolozane

Crystalline form of a β-lactamase inhibitor

Vitamin E formulations of sulfamide NS3 inhibitors

Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...

Quinuclidine derivatives and their use as muscarinic M3 receptor an...

Quinuclidine derivatives and their use as muscarinic m3 receptor an...

Patents Applicationslast 30 patents

SALT FORMS OF CEFTOLOZANE

CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR

CRYSTALLINE FORM OF A BETA-LACTAMASE INHIBITOR

Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...

VITAMIN E FORMULATIONS OF SULFAMIDE NS3 INHIBITORS

QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR AN...

Salts and crystall forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinoli...

Organic Compounds